Shanghai Menon Animal Nutrition Technology Co., Ltd. (SHE:301156)
China · Delayed Price · Currency is CNY 21.04
+0.54 (2.63%)
May 8, 2026, 3:04 PM CST
SHE:301156 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 620.44 | 561.27 | 489.39 | 497.95 | 470.12 | 540.85 |
Other Revenue | - | - | 0.54 | 6.47 | 13.19 | 5.4 |
| 620.44 | 561.27 | 489.93 | 504.42 | 483.32 | 546.25 | |
Revenue Growth (YoY) | 26.14% | 14.56% | -2.87% | 4.37% | -11.52% | 29.89% |
Cost of Revenue | 426.5 | 389.28 | 350.27 | 354.56 | 344.25 | 385.77 |
Gross Profit | 193.93 | 171.99 | 139.66 | 149.86 | 139.07 | 160.49 |
Selling, General & Admin | 92.24 | 86.06 | 69.76 | 72.83 | 61.67 | 63.74 |
Research & Development | 25.6 | 24.84 | 20.88 | 21.97 | 21.38 | 22.53 |
Other Operating Expenses | -1.08 | -0.87 | 2.04 | 2.39 | 2.06 | 2.02 |
Operating Expenses | 116.76 | 110.03 | 94.05 | 94.53 | 87.55 | 87.81 |
Operating Income | 77.17 | 61.96 | 45.61 | 55.33 | 51.52 | 72.68 |
Interest Expense | - | - | - | - | -0.69 | -1.12 |
Interest & Investment Income | 2.95 | 2.55 | 3.3 | 8.01 | 2.61 | 3.13 |
Currency Exchange Gain (Loss) | - | - | 2.33 | 0.93 | 4.34 | -1.46 |
Other Non Operating Income (Expenses) | -5.27 | -0.64 | -0.21 | 0.11 | -0.39 | -0.23 |
EBT Excluding Unusual Items | 74.86 | 63.87 | 51.02 | 64.38 | 57.38 | 73 |
Gain (Loss) on Sale of Investments | -0.22 | -0.22 | 1.32 | -0.01 | -0.72 | 0.39 |
Gain (Loss) on Sale of Assets | -0.01 | -0 | 0.35 | 0.03 | -0.02 | -0 |
Asset Writedown | -9.3 | -2.87 | -0.04 | - | - | -0.08 |
Other Unusual Items | - | - | 3.14 | 5.82 | 1.64 | 6.21 |
Pretax Income | 65.34 | 60.77 | 55.8 | 70.22 | 58.28 | 79.53 |
Income Tax Expense | 5.96 | 5.96 | 6.22 | 7.17 | 5.79 | 8.97 |
Net Income | 59.38 | 54.81 | 49.58 | 63.05 | 52.49 | 70.56 |
Net Income to Common | 59.38 | 54.81 | 49.58 | 63.05 | 52.49 | 70.56 |
Net Income Growth | 21.48% | 10.54% | -21.35% | 20.11% | -25.60% | 5.76% |
Shares Outstanding (Basic) | 141 | 141 | 144 | 145 | 127 | 109 |
Shares Outstanding (Diluted) | 141 | 141 | 144 | 145 | 127 | 109 |
Shares Change (YoY) | -1.44% | -2.06% | -0.82% | 13.96% | 17.08% | -0.52% |
EPS (Basic) | 0.42 | 0.39 | 0.34 | 0.43 | 0.41 | 0.65 |
EPS (Diluted) | 0.42 | 0.39 | 0.34 | 0.43 | 0.41 | 0.65 |
EPS Growth | 23.25% | 12.87% | -20.71% | 5.39% | -36.46% | 6.31% |
Free Cash Flow | -68.99 | -51.36 | 11.22 | 21.56 | -7.63 | -35.76 |
Free Cash Flow Per Share | -0.49 | -0.36 | 0.08 | 0.15 | -0.06 | -0.33 |
Dividend Per Share | - | - | 0.320 | 0.550 | 0.330 | - |
Dividend Growth | - | - | -41.82% | 66.87% | - | - |
Gross Margin | 31.26% | 30.64% | 28.51% | 29.71% | 28.77% | 29.38% |
Operating Margin | 12.44% | 11.04% | 9.31% | 10.97% | 10.66% | 13.30% |
Profit Margin | 9.57% | 9.77% | 10.12% | 12.50% | 10.86% | 12.92% |
Free Cash Flow Margin | -11.12% | -9.15% | 2.29% | 4.28% | -1.58% | -6.55% |
EBITDA | 104.54 | 88.48 | 68.73 | 74.59 | 61.48 | 80.48 |
EBITDA Margin | 16.85% | 15.77% | 14.03% | 14.79% | 12.72% | 14.73% |
D&A For EBITDA | 27.37 | 26.52 | 23.13 | 19.26 | 9.96 | 7.8 |
EBIT | 77.17 | 61.96 | 45.61 | 55.33 | 51.52 | 72.68 |
EBIT Margin | 12.44% | 11.04% | 9.31% | 10.97% | 10.66% | 13.30% |
Effective Tax Rate | 9.12% | 9.81% | 11.14% | 10.22% | 9.94% | 11.28% |
Revenue as Reported | - | - | 489.93 | 504.42 | 483.32 | 546.25 |
Advertising Expenses | - | - | 1.95 | 1.82 | 0.36 | 0.35 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.